Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 8NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Malignant Solid Neoplasm 2Teratoma 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Peritoneal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Acute 1Hepatitis B 1Hematopoietic and Lymphatic System Neoplasm 1Endodermal Sinus Tumor 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Carcinoma, Embryonal 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Triptorelin Pamoate 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Organizational Objectives 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hematopoietic and Lymphatic System Neoplasm × Practice Guidelines as Topic × Clear all
NCT06513962 2026-05-05

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Children's Oncology Group

Phase 3 Recruiting
60 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡